Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral cannabis oil for fibromyalgia syndrome
ACTRN12623000345684Phase 2Completed
- Sponsor
- Southern Cross University
- Start
- Aug 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Cannabis oil with Placebo oil (2 arms). Primary endpoints: Ratio of screened to enrolled participants, Accrual rate and 11 more. Started Aug 2023; status: completed.
02
Drugs
cannabis oil
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on ACTRN12623000345684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000345684.